Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Behav Brain Res ; 287: 82-8, 2015.
Article in English | MEDLINE | ID: mdl-25746513

ABSTRACT

Cholinergic input to the ventral tegmental area (VTA), origin of the mesocorticolimbic dopamine system that is critical for cocaine reward, is important for both cocaine seeking and cocaine taking. The laterodorsal tegmental nucleus (LDTg) provides one of the two major sources of excitatory cholinergic input to the VTA, but little is known of the role of the LDTg in cocaine reward. LDTg cholinergic cells express urotensin-II receptors and here we used local microinjections of a conjugate of the endogenous ligand for these receptors with diphtheria toxin (Dtx::UII) to lesion the cholinergic cells of the LDTg in rats previously trained to self-administer cocaine (1mg/kg/infusion, i.v.). Lesioned rats showed long latencies to initiate cocaine self-administration after treatment with the toxin, which resulted in a reduction in cocaine intake per session. Priming injections reduced latencies to initiate responding for cocaine in lesioned rats, and once they began to respond the rats regulated their moment-to-moment cocaine intake within normal limits. Thus we conclude that while LDTg cholinergic cell loss does not significantly alter the rewarding effects of cocaine, LDTg lesions can reduce the rat's responsiveness to cocaine-predictive stimuli.


Subject(s)
Cholinergic Neurons/physiology , Cocaine/administration & dosage , Drug-Seeking Behavior/physiology , Pedunculopontine Tegmental Nucleus/physiology , Animals , Cholinergic Neurons/drug effects , Diphtheria Toxin/toxicity , Drug-Seeking Behavior/drug effects , Male , Pedunculopontine Tegmental Nucleus/drug effects , Rats , Rats, Long-Evans , Self Administration
2.
Eur J Neurosci ; 35(6): 870-82, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22356593

ABSTRACT

Early cognitive deficits are increasingly recognized in patients with Parkinson's disease (PD), and represent an unmet need for the treatment of PD. These early deficits have been difficult to model in mice, and their mechanisms are poorly understood. α-Synuclein is linked to both familial and sporadic forms of PD, and is believed to accumulate in brains of patients with PD before cell loss. Mice expressing human wild-type α-synuclein under the Thy1 promoter (Thy1-aSyn mice) exhibit broad overexpression of α-synuclein throughout the brain and dynamic alterations in dopamine release several months before striatal dopamine loss. We now show that these mice exhibit deficits in cholinergic systems involved in cognition, and cognitive deficits in domains affected in early PD. Together with an increase in extracellular dopamine and a decrease in cortical acetylcholine at 4-6 months of age, Thy1-aSyn mice made fewer spontaneous alternations in the Y-maze and showed deficits in tests of novel object recognition (NOR), object-place recognition, and operant reversal learning, as compared with age-matched wild-type littermates. These data indicate that cognitive impairments that resemble early PD manifestations are reproduced by α-synuclein overexpression in a murine genetic model of PD. With high power to detect drug effects, these anomalies provide a novel platform for testing improved treatments for these pervasive cognitive deficits.


Subject(s)
Brain/pathology , Cognition Disorders/etiology , Parkinson Disease/complications , alpha-Synuclein/metabolism , Animals , Brain/metabolism , Cognition Disorders/metabolism , Cognition Disorders/pathology , Disease Models, Animal , Humans , Immunohistochemistry , Male , Maze Learning , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Parkinson Disease/metabolism , Parkinson Disease/pathology , alpha-Synuclein/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...